Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee
Home
Primary Antibodies
MIF Antibodies
Imalumab Biosimilar - Anti-MIF Antibody (PE) (A334056)
Imalumab Biosimilar - Anti-MIF Antibody (PE) (A334056)
Overview
Specifications
Recombinant Antibody
$349
Product Datasheet
Recombinant human monoclonal antibody to MIF (PE) for Flow Cytometry.
100% Guarantee
Price Match Guarantee
Product Size:
100T
Quantity:
1
2
3
4
5
6
7
8
9
10
Add To Cart
Request a Quotation
Custom or Bulk Request
Alternative Formats and Conjugates
Alternative Formats
Biotin
Carrier Free and Preservative Free
Shipping Information
Freight/Packing Charges:
$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Tags:
Recombinant Antibody
Specifications
Name
Imalumab Biosimilar - Anti-MIF Antibody (PE)
Description
Recombinant human monoclonal antibody to MIF (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate
PE
Excitation: 565nm, Emission: 578nm
Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
EC:5.3.3.12, GIF, GLIF, Glycosylation-inhibiting factor, L-dopachrome isomerase, L-dopachrome tautomerase, Macrophage migration inhibitory factor, MMIF, Phenylpyruvate tautomerase
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Imalumab Biosimilar - Anti-MIF Antibody (PE) (A334056)? Please
let us know
so that we can list the citation on this page.
Proteins predicted to interact with MIF
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
CD74 Antibodies
99.9% Relevancy Score
CXCR2 Antibodies
99.3% Relevancy Score
CXCR4 Antibodies
99.1% Relevancy Score
JAB1 Antibodies
97.6% Relevancy Score
GOT2 Antibodies
92.9% Relevancy Score
GOT1 Antibodies
91.5% Relevancy Score
ATTY Antibodies
91% Relevancy Score
HPD Antibodies
90.9% Relevancy Score
CD44 Antibodies
86.3% Relevancy Score
Top
